Skip to content
  • Sunday, 26 July 2026
  • 3:21 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Pharma Manufacturing Facility Sales to Outsourcers Signal Growing Industry Demand for Strategic Flexibility
Pharmaceutical R&D

Pharma Manufacturing Facility Sales to Outsourcers Signal Growing Industry Demand for Strategic Flexibility

Teuku Ryan May 12, 2026 0

A notable surge in the acquisition of pharmaceutical manufacturing facilities by contract development and manufacturing organizations (CDMOs) has illuminated a…

Read More
Clinical Diagnostics & Pathology

Rising Therapy-Related Leukemia Rates Signal New Testing Demands for Clinical Labs

Reynand Amr Wu May 6, 2026 0

A recent population-based study, published in CANCER, a prestigious journal of the American Cancer Society, has brought to light a…

Read More
Clinical Diagnostics & Pathology

Rising Therapy-Related Leukemia Rates Signal New Testing Demands for Clinical Labs

Reynand Amr Wu Apr 29, 2026 0

The landscape of cancer care is undergoing a profound transformation, marked by significant advancements in diagnostics and therapeutics that have…

Read More
Clinical Diagnostics & Pathology

Rising Therapy-Related Leukemia Rates Signal New Testing Demands for Clinical Labs

Reynand Amr Wu Apr 21, 2026 0

The landscape of cancer care is undergoing a profound transformation, marked by significant advancements in treatment modalities that have dramatically…

Read More
Clinical Diagnostics & Pathology

Rising Therapy-Related Leukemia Rates Signal New Testing Demands for Clinical Labs

Reynand Amr Wu Apr 14, 2026 0

A new population-based study, published in CANCER, a journal of the American Cancer Society, has brought into sharp focus a…

Read More

Posts pagination

1 2
From list price to net price: How finance leaders decode real drug costsGilead Acquires Antibody-Drug Conjugate Pioneer Tubulis for Up to $5 Billion, Bolstering Oncology PipelineGoogle’s TurboQuant Redefines AI Efficiency with Extreme Compression and Performance GainsMidlife Vitamin D Levels Linked to Lower Alzheimer’s Tau Biomarker; Study Signals Implications for Clinical Labs
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ